Siemens Healthineers reported strong revenues in the fourth quarter and full fiscal year of 2025 compared with last year, noting growth despite a "challenging environment."
For the fourth quarter (end-30 September), the company’s revenue was €6.322 billion, up 3.7% from the same period last year. Siemens' net income dipped 4%, however, to €597 million, compared with €624 million in the fourth quarter last year.
Higher tariffs had a negative effect on all segments, although this was offset in particular by strong revenue development in the Imaging segment, Siemens noted. Revenue in the Imaging segment rose to €3.647 billion, up 6.5% on a comparable basis with last year, with Molecular Imaging achieving sharp growth. Revenue in the company’s Varian segment rose by 1.4% to €1.088 billion compared with a very strong fourth quarter last year.
From a geographical perspective, the Americas region showed strong comparable revenue growth, while revenue in the Asia Pacific Japan region grew moderately, and revenue in the China region declined by a low single-digit percentage range, Siemens said.
For the full fiscal year 2025, Siemens' revenues rose to €23.375 billion, up 5.9% from €22.363 billion in fiscal year 2024, the company said. The company’s net income in 2025 was €2.168 billion, up from €1.959 billion in 2024, Siemens reported.
The company’s Imaging segment had total adjusted revenues of €13.182 billion in fiscal year 2025, up 8.5% from €12.267 billion in 2024. The company’s Varian segment contributed with very strong revenue growth, with revenues of €4.081 billion, up 6.9% from €3.866 billion last year, according to the company.
From a geographical perspective, the significant year-on-year revenue development in the Americas region contributed most clearly to the company’s growth. In the Asia Pacific Japan region, revenue rose strongly and, in the EMEA (Europe, the Middle East, and Africa) region, slightly, Siemens said.
Meanwhile, the China region showed a slight revenue decline, the company noted.
